Urology consultation: MRI of a male pelvis showing the bladder and the prostate. Most men with localized prostate cancer do not die within 15 years, whether or not they receive active surveillance or ...

In patients with localized prostate cancer, stereotactic body radiotherapy (SBRT) was associated with better urinary continence and sexual function, but slightly worse bowel function, compared with ...

Please provide your email address to receive an email when new articles are posted on . Prostate cancer-specific mortality appeared comparable among those assigned prostatectomy, radiotherapy or ...

A new Moffitt Cancer Center study suggests a widely used genomic test can more accurately identify which men with early ...

MILAN — Men newly diagnosed with localized prostate cancer can rest assured that whatever their initial choice of therapy — whether surgery, radiation, or active monitoring — all will have a high ...

Survival curves for men treated with and without add-on docetaxel converged with longer follow-up. Based on 10 years of trial follow-up data, docetaxel should not be used to treat high-risk localized ...

CAN-2409 resulted in disease-free survival improvements for patients with high-risk, localized prostate cancer. Among patients with localized prostate cancer, the viral immunotherapy CAN-2409 has ...

Stage 3 prostate cancer is locally advanced, with tumors extending beyond the prostate but not metastasizing distantly.

Forms of localized treatment have potential to positively impact the survival rate and prognosis of men diagnosed with certain forms of metastatic prostate cancer. Localized treatment focusing on the ...

High risk prostate cancer means that tumors may be at risk of spreading beyond the prostate or have already done so. Prostate cancers are divided into one of three risk groups: low, intermediate, and ...